Christopher

Analyst

JPMorgan (covering for colleague)

Equibles does not estimate personal net worth.

About Christopher

Christopher is recorded as Analyst at JPMorgan (covering for colleague). Christopher has spoken on 2 earnings calls across 2 companies, most recently for Halozyme Therapeutics, Inc. on January 28, 2026. Those appearances were for Halozyme Therapeutics, Inc. (HALO) and Prologis, Inc. (PLD). The companies whose calls Christopher spoke on are classified in the Healthcare and Real Estate sectors.

Christopher on recent calls

“We recognize the potential for Enhance to improve the clinical profile and deliver convenience of two emerging and rapidly growing classes of drugs, antibody drug conjugates and nucleic We initiated a series of internal experiments in collaborations with leading companies to generate data to evaluate and demonstrate…”

Halozyme Therapeutics, Inc. Q4 FY2025 Earnings Call · January 28, 2026

“Michael, let me give you the full fundamental forecast for 26 so that you have all the context you need to make that judgment. The key message here is market vacancies are poised to improve over the course of the year.”

Prologis, Inc. Q4 FY2025 Earnings Call · January 21, 2026